- Published 2026
- No of Pages: 120+
- 20% Customization available
Zinc Oxide-Eugenol (ZOE) dental cements Market | Latest Statistics, Business Trends, Growth and Opportunities
Market Summary and Growth Forecast
The global Zinc Oxide-Eugenol (ZOE) dental cements Market will witness a robust CAGR of 4.8%, valued at $0.19 billion in 2026, expected to appreciate and reach $0.29 billion by 2035.
The Zinc Oxide-Eugenol (ZOE) dental cements Market covers dental cement formulations made mainly from zinc oxide powder and eugenol-based liquid systems. These materials are used across temporary restorations, provisional luting, cavity bases, liners, intermediate restorative procedures, and selected endodontic or sedative applications. ZOE remains relevant because it solves a very practical clinical need: it is easy to place, offers a calming effect on irritated dentin, gives a tight short-term seal, and can be removed without the difficulty linked to permanent adhesive systems. Clinical literature still describes ZOE as useful in provisional filling, luting, and sedative dental applications.
In 2026, the market sits in a mature but stable pocket of the broader dental materials industry. It is not a high-fashion restorative material like resin cements or bioactive glass ionomer systems. That said, it continues to be purchased because general dentists, endodontists, public dental clinics, and teaching institutions need dependable temporary cement at predictable cost. The market’s strategic value is therefore less about premium pricing and more about recurring procedure-led demand.
| Metric | Estimate / Position |
| Global Market Size, 2026 | $0.19 billion |
| Projected Market Size, 2035 | $0.29 billion |
| CAGR, 2026–2035 | 4.8% |
| Volume Character | High repeat usage, low-to-mid unit price |
| Demand Base | Dental clinics, hospitals, academic dental colleges, public oral-health programs |
| Product Positioning | Temporary, sedative, intermediate, and provisional dental cement |
Growth from 2026 to 2035 will be shaped by four forces. First, dental treatment volumes are rising in emerging markets as private clinics expand and public oral-health coverage improves. Second, ageing populations are increasing demand for crowns, bridges, root-canal treatment, and interim restorative work. Third, product formats are becoming easier to use, with pre-measured packs, cleaner mixing systems, and improved consistency. Fourth, regulation is pushing manufacturers to maintain cleaner documentation around composition, biocompatibility, labeling, and safe clinical use. In the U.S., zinc oxide-eugenol dental cement is recognized under FDA dental device product classification for dental cement, which keeps the category inside a defined medical-device framework.
The real story is not that ZOE will replace modern adhesive cements. It won’t. The stronger view is that ZOE keeps its place because dentists still need a forgiving temporary material, especially when the final restoration plan is not yet closed.
The Zinc Oxide-Eugenol (ZOE) dental cements Market is also affected by material substitution. Eugenol-free temporary cements are gaining share where resin-based restorations are used because eugenol may interfere with resin polymerization. Large dental material suppliers actively market non-eugenol zinc oxide temporary cements for these use cases, showing that the broader temporary cement category is moving toward compatibility with resin workflows. Still, conventional ZOE holds demand where its sedative effect, low irritation, and low cost remain more important than resin compatibility.
Key Stakeholders in the Market
| Stakeholder Group | Role in Market Development |
| Dental material manufacturers | Develop ZOE powder-liquid systems, reinforced ZOE, temporary filling materials, and related cement kits |
| Dental clinics and DSOs | Drive recurring consumption through temporary restorations, crown trials, and emergency care |
| Hospitals and public dental centers | Use ZOE in cost-sensitive restorative and emergency dental procedures |
| Dental colleges and training institutes | Support baseline demand through teaching, pre-clinical labs, and student procedures |
| Distributors and dental dealers | Control product availability, pack-size movement, and regional price competitiveness |
| Regulators and standards bodies | Influence labeling, safety documentation, device registration, and material performance expectations |
| Investors and strategic buyers | Track niche dental consumables as steady-margin recurring product categories |
From a production standpoint, the category is not heavily constrained by complex manufacturing. The core inputs are mature and globally available. The bigger differentiators are quality control, powder-liquid consistency, handling time, packaging integrity, shelf stability, and distributor reach. This gives established dental brands an advantage, but it also leaves room for regional manufacturers in India, China, Southeast Asia, Latin America, and Eastern Europe.
By 2035, the Zinc Oxide-Eugenol (ZOE) dental cements Market should remain a focused consumables category. It will grow slower than premium resin-based luting systems but remain more resilient than many legacy dental materials because it serves a real clinical gap. The best-positioned suppliers will be those that offer both traditional ZOE and non-eugenol alternatives, allowing dentists to choose based on procedure type rather than switching supplier altogether.
Competitive Intelligence and Benchmarking
The Zinc Oxide-Eugenol (ZOE) dental cements Market is moderately fragmented. A few global dental-material brands control premium clinic demand, while regional manufacturers serve price-sensitive markets with powder-liquid systems, reinforced ZOE, eugenol liquids, zinc oxide powders, and temporary filling kits. The competitive base is not driven by one breakthrough technology. It is driven by trust, dentist familiarity, distribution reach, handling quality, and clinical workflow fit.
| Company | Relevant Portfolio Position | Market Position and Benchmarking View |
| Dentsply Sirona | Offers broad restorative and temporary cement solutions across dental consumables. Its regulatory registrations include zinc oxide-eugenol dental cement in markets such as Australia. | A leading global dental consumables and equipment player. Strong in institutional procurement, dental chains, academic use, and premium private clinics. Its advantage is not only product availability but also brand confidence and bundled restorative workflows. |
| Kerr Dental | Active in temporary cement systems including ZOE-based and eugenol-free formats for provisional crowns, bridges, splints, and trial cementation. | One of the strongest names in temporary cement. Its position is supported by long-standing dentist familiarity and a clear bridge between traditional ZOE and resin-compatible alternatives. |
| GC Corporation | Strong in dental materials, restorative systems, and cement technologies. Historical patent activity also shows ZOE formulation work for temporary sealing and luting applications. | A premium Japanese dental-materials company with strong clinical credibility. GC is more diversified beyond ZOE, but its technical strength in cements and restorative materials keeps it relevant in this category. |
| Septodont | Active in dental pharmaceutical and endodontic materials. Its zinc oxide-eugenol-based endodontic cement systems are positioned around root canal obturation and radiographic follow-up. | Stronger in endodontic and dental pharmaceutical channels than in general restorative cement alone. Septodont’s position is important where ZOE overlaps with root canal sealing and medicated dental procedures. |
| Prevest DenPro | Offers reinforced ZOE cement, zinc oxide powder, and eugenol liquid systems. Its products target temporary restoration, cavity lining, base applications, and emergency dental procedures. | A relevant India-based manufacturer with strong fit for emerging-market demand. It competes well where dentists need acceptable performance, smaller pack sizes, and local distribution economics. |
| Prime Dental Products | Offers zinc oxide-eugenol cement in powder-liquid formats and reinforced quick-setting systems for temporary filling, pulp capping, and cavity lining applications. | A regional supplier with clear ZOE participation. Its strength is in practical consumables for clinics that value affordability, quick handling, and standard restorative use. |
| Shofu Dental | Offers dental cement systems across restorative categories, including temporary cement materials and adjacent non-eugenol alternatives. | A well-known Japanese dental materials company with credibility in Asia and export markets. Its broader cement portfolio helps it stay relevant as clinics move between ZOE, zinc phosphate, glass ionomer, and resin-based systems. |
The competitive risk for traditional ZOE is not disappearance. It is gradual substitution in cases where dentists need resin compatibility. So the strongest players are those that don’t force a binary choice. They offer ZOE where it fits and non-eugenol cement where it doesn’t.
In 2026, Dentsply Sirona and Kerr Dental remain better positioned in premium and organized dental channels. GC Corporation and Shofu Dental hold strong technical and brand credibility in Asia-led material markets. Septodont is more specialized, especially where ZOE is linked with endodontics. Prevest DenPro and Prime Dental Products are important for India, the Middle East, Africa, and value-led private clinics.
Regional Landscape and Adoption Outlook
Regional demand in the Zinc Oxide-Eugenol (ZOE) dental cements Market follows the structure of dental care access. Mature markets buy more through branded distributors and dental service organizations. Emerging markets buy more through fragmented private clinics, dental colleges, public hospitals, and local dealers.
| Region | 2026 Adoption Outlook | Growth Direction to 2035 |
| North America | High dentist familiarity, strong use in temporary crown and bridge procedures, emergency fillings, and teaching institutions. Demand is steady but substitution toward eugenol-free temporary cements is visible in resin-heavy workflows. | Moderate growth. The U.S. remains the main revenue contributor due to high procedure value, insurance-linked dentistry, and mature private clinics. ADA continues to track dental utilization and expenditure trends across the U.S. dental care market. |
| Europe | Stable demand across Germany, France, Italy, Spain, and the U.K. Public dental systems and private clinics both influence procurement. Regulatory compliance and product documentation are important. | Low-to-moderate growth. Western Europe is mature. Eastern Europe offers more room through clinic modernization and private dental investment. |
| China | Large dental patient pool, growing private dental chains, and rising restorative treatment penetration. Local manufacturing and import brands compete closely. | Strong growth. China is likely to remain one of the largest incremental demand pools because of urban clinic expansion and rising cosmetic-restorative treatment volumes. |
| India | High clinical need, large number of dental colleges, rising private clinics, and strong local manufacturing. ZOE remains attractive because it is cost-effective and familiar to general dentists. | High growth. India’s oral-health gap, uneven infrastructure, and economic barriers create large unmet treatment demand, especially outside metro cities. |
| Japan | Mature dental-care infrastructure and strong domestic dental-material companies. ZOE use is more selective because advanced restorative systems are widely available. | Modest growth. Japan remains valuable for high-quality materials and specialized dental procedures rather than volume-led expansion. |
| South Korea | Digitally advanced clinics and high restorative procedure intensity. ZOE is used where temporary and sedative cementing still fits the treatment plan, although premium resin and non-eugenol alternatives are common. | Moderate growth. Demand will be supported by ageing patients and prosthodontic workflows, but premium substitution limits aggressive ZOE expansion. |
| Rest of the World | Latin America, Southeast Asia, the Middle East, and Africa show mixed adoption. Urban private clinics use branded products, while public and semi-urban clinics often rely on affordable regional suppliers. | Above-average growth. White space is strongest in underserved public dental systems, rural clinics, and dental training institutions. WHO continues to highlight oral diseases as a major global burden, which supports long-term demand for basic restorative materials. |
North America and Europe are revenue-heavy regions. Asia Pacific is the growth engine. LAMEA is smaller in value but important in volume because ZOE fits lower-cost restorative and emergency dental care.
The white space is not only in big cities. It is in Tier-2 clinics, dental schools, mobile dental units, and government-supported oral-health programs where affordable temporary restorative materials are still practical.
By 2035, India, China, Southeast Asia, Brazil, Mexico, and selected Gulf countries should contribute a larger share of incremental demand. Japan, South Korea, the U.S., Germany, and France will remain important for premium branded sales but will not define volume growth.
End-User Dynamics and Use Case
End-user demand in the Zinc Oxide-Eugenol (ZOE) dental cements Market is shaped by procedure type, budget, dentist preference, and restoration plan. ZOE is not used everywhere. It is selected when temporary sealing, sedative effect, provisional cementation, or intermediate restoration is more important than long-term adhesive bonding.
| End User | Adoption Pattern | Buying Logic |
| Private dental clinics | Use ZOE for temporary crowns, bridge trials, emergency fillings, cavity bases, and provisional restorations. | Prefer trusted brands, predictable setting time, easy cleanup, and smaller packs. |
| Dental hospitals | Use ZOE across restorative, endodontic, and emergency departments. | Need consistent supply, institutional pricing, and products that can be used by multiple clinicians. |
| Dental colleges and teaching institutes | Use ZOE for pre-clinical training, student procedures, temporary restorations, and basic material demonstrations. | High repeat demand. Price and availability matter more than premium packaging. |
| Public dental programs | Use ZOE where temporary treatment and pain-relief-oriented care are required in cost-sensitive settings. | Demand is linked to public procurement, rural outreach, and basic dental-care access. |
| Dental service organizations | Use more standardized product lists. ZOE is retained where workflows require temporary cement with easy removal. | Prefer reliable supply, brand consistency, and compatibility with clinic protocols. |
Use case: A tertiary hospital in South Korea used ZOE cement in its restorative dentistry department for short-term sealing after caries excavation in patients scheduled for definitive crown or indirect restoration at a later visit. The material was selected for cases where the dentist wanted a temporary seal, patient comfort, and easy removal before final cementation. In resin-based final restoration cases, the hospital shifted toward non-eugenol temporary cement to avoid bonding interference. This is a realistic clinical split: ZOE remains useful, but it is not the default for every provisional workflow.
This end-user pattern explains why the market is stable. ZOE is not trying to compete with every modern adhesive cement. It survives because it answers a narrower clinical problem very well.
Recent Developments + Opportunities & Restraints
Recent Developments
| Year / Month | Event | Impact on the Market |
| 2026 / February | Dentsply Sirona released its full-year 2025 results and 2026 outlook, keeping focus on its broad dental consumables, equipment, and workflow portfolio. | Supports the role of large integrated dental suppliers in maintaining distribution strength for mature consumables, including temporary cement categories. |
| 2025 / April | Dentsply Sirona reported that it invested about 4% of revenue into R&D in 2024 and highlighted workflow-focused dental innovation. | While not ZOE-specific, it shows that major dental-material companies are investing in workflow efficiency, which influences packaging, handling, and chairside material adoption. |
| 2025 / March | WHO updated its oral-health fact sheet, noting that most oral-health conditions are preventable and treatable in early stages. | Reinforces demand for basic restorative materials and temporary treatment products in public and private dental systems. |
| 2025 / January | A clinical review on India’s oral-health outlook highlighted low awareness, infrastructure gaps, and economic barriers. | Strengthens the case for affordable dental consumables in India, especially in public clinics, dental colleges, and non-metro private practices. |
| 2024 / January | Prime Dental Products revised its safety documentation for polymer-reinforced zinc oxide-eugenol quick-setting cement. | Shows active documentation and compliance maintenance by regional manufacturers supplying ZOE materials. |
Sources: Dentsply Sirona investor releases and annual report; WHO oral-health fact sheet; India oral-health clinical review; Prime Dental Products safety data sheet.
Opportunities
| Opportunity | Why It Matters |
| Emerging-market clinic expansion | India, China, Southeast Asia, Latin America, and Africa still have large untreated dental populations. Affordable temporary cements fit these markets well. |
| Dental college and training demand | ZOE remains useful in education because students need to understand temporary filling, lining, luting, and sedative material behavior. |
| Reinforced and easier-to-handle formats | Polymer-reinforced ZOE, quick-set packs, better powder-liquid consistency, and cleaner dispensing can help suppliers defend demand against substitutes. |
Restraints
| Restraint | Market Impact |
| Substitution by eugenol-free materials | Dentists often avoid eugenol where resin restorations or adhesive bonding are planned. This limits ZOE use in cosmetic and high-end prosthodontic workflows. |
| Low-margin product economics | ZOE is a mature consumable. Price competition is high, especially in emerging markets. |
| Limited premium positioning | Compared with resin cements and bioactive restorative materials, ZOE has less innovation appeal. Growth depends more on procedure volume than pricing power. |
The opportunity is practical rather than glamorous. Suppliers that treat ZOE as a dependable clinical workhorse, not a premium innovation story, will read this market correctly.
“Every Organization is different and so are their requirements”- Datavagyanik
Companies We Work With
Do You Want To Boost Your Business?
drop us a line and keep in touch
